Karnataka bans fee hikes for nursing courses, threatens penalties for colleges charging above approved rates
Medical Education and Skill Development Minister Sharanaprakash Patil made this clear during a meeting with the Association of Nursing Colleges held at Vikasa Soudha on Thursday.
"The government will not allow any fee increase. Most nursing students come from rural and economically disadvantaged backgrounds. Imposing additional fees is unjust and unacceptable," said Minister Patil, rejecting the association's plea to raise the fees.
He stated that the existing fee structure -- Rs 10,000 under the government quota, Rs 1 lakh under the management quota and Rs 1.4 lakh for non-Karnataka students -- will continue.
"Any college charging more than the approved fee will face penalties and legal action. We will not hesitate to revoke their affiliation," he asserted.
Currently, there are 611 nursing colleges in the state with around 35,000 seats. Of these, 80 per cent are filled by the management, and 20 per cent fall under the government quota.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Giá vàng đang tăng mạnh trong năm 2025 — Các nhà giao dịch thông minh đã tham gia
IC Markets
Tìm hiểu thêm
Undo
The minister also directed Karnataka Examination Authority (KEA) Director H. Prasanna to ensure reimbursement of fees to nursing colleges within 30 days. He further clarified that only the state government will decide on filling unallocated seats, closing the door to any unauthorised changes.
The Karnataka government on May 17 had declared that there will be no increase in the fee structure for medical and dental courses in the upcoming academic year, despite pressure from private medical colleges.
Private colleges had appealed for a 10 per cent to 15 per cent hike in fees. However, the minister stated that although the government had allowed a 10 per cent increase last year, no fee hike will be permitted this year.
In September 2024, Minister Sharan Prakash Patil ordered the formation of a fee regulatory committee to monitor and regulate the fee structures of nursing colleges across the state following the complaints about exorbitant fees allegedly charged by them.
The five-member fee regulatory committee is headed by the Joint Secretary of the Medical Education Department.
Patil had also instructed to withdraw the Essential and Feasibility Certificate (EC & FC) of any nursing college found imposing fees beyond government-prescribed limits.
In a move against substandard para-medical colleges, Minister Patil had also directed officials to withdraw affiliations and shut down institutions failing to meet infrastructure and teaching standards.
Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Aayush Wellness expands nutraceutical product portfolio
Aayush Wellness on Monday announced the expansion of its nutraceutical product portfolio with the launch of a capsule to support cognitive function and memory retention . With this launch, the company continues to expand its nutraceutical product portfolio, addressing one of the most overlooked health challenges in modern society like poor memory and lack of focus, Aayush Wellness said in a statement. The company seeks to capitalise on the USD 18 billion Indian nutraceutical industry, which is growing at a CAGR of over 15 per cent, Aayush Wellness said. On the launch of Brain Fuel Capsules , the company stated that due to increasing demands of modern life, millions of individuals, including students, working professionals, and the elderly, are experiencing early signs of cognitive decline, such as forgetfulness and poor concentration. "We believe that true wellness starts from within, and brain health is central to overall well-being," said Naveena Kumar, Managing Director of Aayush Wellness Limited. Live Events The company last month announced its foray into tele-consultation and diagnostic testing segments. It also announced a Rs 25 crore investment recently to expand its preventive healthcare services with smart health kiosks in the initial phase.
Time of India
an hour ago
- Time of India
AstraZeneca drug lowers high blood pressure in late-stage study
AstraZeneca said on Monday its experimental drug baxdrostat significantly lowered blood pressure in a late-stage trial of patients with treatment-resistant hypertension. The news sent shares of the Anglo-Swedish drugmaker up by almost 2%. The company said it expects peak annual sales for the drug to exceed $5 billion, driven by its use as a standalone therapy and in combination with Farxiga , its blockbuster treatment - one that generates $1 billion or more in annual sales - for type 2 diabetes, heart failure and chronic kidney disease . by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 15 Most Beautiful Female Athletes in the World Click Here Undo Baxdrostat met the main and secondary goals of the study, showing a statistically significant and clinically meaningful reduction in systolic blood pressure at 12 weeks when added to standard treatment at two doses, and compared with placebo, AstraZeneca said. It acquired baxdrostat through its 2023 purchase of CinCor Pharma as part of efforts to expand its pipeline in heart and kidney disease. Live Events The drug targets aldosterone, a hormone that raises blood pressure, offering a new approach distinct from older treatments like ACE inhibitors that do not address hormonal drivers, AstraZeneca says. High blood pressure affects more than 1 billion people worldwide, according to the World Health Organization. AstraZeneca is testing baxdrostat in four indications, including chronic kidney disease and prevention of heart failure, in a clinical programme involving more than 20,000 patients. Shares in London's biggest listed company by market value were up 1.9% at 0834 GMT and among the top gainers on the FTSE 100 index in early trading. Mineralys Therapeutics is developing a similar drug, lorundrostat, and expects to submit data to the U.S. Food and Drug Administration by the end of the year. AstraZeneca said it will present full trial results at a medical conference in August but did not say when it will seek U.S. approval. Its shares are flat this year to date though they have outperformed Europe's benchmark healthcare index by about 5.5%, Barclays analysts said in a note on Monday.
Mint
2 hours ago
- Mint
Check these deductions in Income Tax Act before filing your tax returns
Taxpayers often stick to general known deductions like 80C, 80D, etc, but miss out on some other significant deductions, which can reduce tax liability. Before one sends the return, one must take time to revisit the financial year. A little awareness can go a long way in reducing the tax burden. The Indian Income Tax Act, 1961, offers numerous deductions to reduce taxable income, yet many taxpayers, while filing returns, miss the lesser-known provisions that can significantly reduce the tax liability if only one remembers to claim them. While popular sections like 80C (investments) and 80D (health insurance) are widely used, unfortunately, many of these are overlooked either due to a lack of awareness or complexity in understanding. Here is a set of lesser-known Income Tax sections that are often overlooked by taxpayers. Exploring them before filing the return could help in significant savings: Section 80GG: Rent Paid Without HRA Most salaried individuals receive House Rent Allowance (HRA), but if you are a professional or other taxpayer individual not receiving HRA but paying rent, Section 80GGallows a deduction. The deduction is allowed up to ₹5,000 per month or 25% of total income, whichever is less. The only condition is that you must not own a house in the same city or location as your workplace. Section 80DDB: Medical Treatment for Specified Diseases For those who have incurred expenses on the treatment of critical illnesses like cancer, Parkinson's, or chronic kidney failure for themselves or their dependents, this section allows a deduction up to ₹40,000 for individuals, and ₹1,00,000 for senior citizens. To claim this deduction, a prescription for such medical treatment from a specialist is required. Section 80DD – Maintenance of a Disabled Dependent This section allows a deduction of Rs. 75,000 (normal disability) or ₹1.25 lakh (severe disability) for expenses incurred on the care of a dependant with a disability. The expenses can be for medical treatment, training, and even life insurance premiums for the dependent. Section 80U: Disability Deduction If a taxpayer is having a disability, he/she is entitled to a flat deduction of ₹.75,000 (40%-80% disability) or ₹1.25 lakh (severe disability, 80% or more) regardless of the actual expenses. To claim this deduction, only a disability certificate from a medical authority is required. The difference between the two provisions–80DD and 80U—is that Section 80DD provides tax deductions to the family members and kin of the taxpayer with a disability, whereas Section 80U provides deductions to the individual taxpayer with a disability himself. Section 80E: Interest on Education Loan Parents or students who have taken loans for higher education can claim a 100% deduction on the interest paid for 8 years (or until full repayment). It is pertinent to mention that there is no limit on the deduction and the higher education can be in India or abroad. Section 80EE: First-Time Homebuyer Interest Deduction This section is applicable for first-time homebuyers. If someone had purchased your first home between April 1, 2016, and March 31, 2017, with the property value should be less than or equal to ₹50 lakh; loan sanctioned amount should be less than or equal to ₹35 lakh, one can claim an additional deduction of Rs. 50,000 annually on the interest paid on the home loan. It is important to mention that the said deduction is over and above the deduction u/s 24(b). Section 80EEA – Affordable Housing Loan Interest This section was introduced in Budget 2019, which provides an additional deduction of up to ₹1.5 lakh for interest on loans taken for affordable housing. The condition is that stamp duty value of the property should be less than or equal to ₹45 lakh, and the loan should have been sanctioned between April 1, 2019, and March 31, 2022. One cannot claim this if already claiming deduction u/s 80EE. Section 80TTB – Interest Income for Senior Citizens Senior citizens, who are 60 years or above can claim a deduction of up to ₹50,000 on interest income earned from bank deposits. The interest income can be from savings accounts, fixed deposits, and recurring deposits. Generally, at the time of filing the return, one focuses only on the return on FDs but forgets savings account interest. Section 10(14): Special Allowances Certain allowances are tax-exempt underRule 2BB. For example, transport allowance for disabled employees, children's education allowance ( ₹100/month per child), hostel allowance ( ₹300/month per child). Many in the workforce do not claim these small but useful exemptions. Section 24(b) – Home Loan Interest (Self-Occupied Property) Often clubbed with Section 80C, this allows up to ₹2 lakh in deductions for interest paid on home loans for self-occupied properties. This section allows deduction even if you are not claiming principal repayment u/s 80C. The only condition is that loan must be taken for purchase or construction and completed within five years. Bharat Dhawan, managing partner, Forvis Mazars in India.
